Conducted in-depth stakeholder interviews on possible reforms in the drug development pipeline as part of a project for the Council on American Medical Innovation, including also assessment of mechanisms used in other nations to promote biomedical innovation.
Benchmarked bioscience cluster development strategies in more than 30 states as part of a project on “driving state economic growth” for the Pharmaceutical Research and Manufacturers Association (PhRMA).